NCT00323492View on ClinicalTrials.gov

TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

March 31, 2008

Conditions
HIV Infections
Interventions
DRUG

Truvada

Truvada + NNRTI or PI.

DRUG

Current HAART regimen

Maintain baseline regimen

Trial Locations (1)

75015

Gilead Sciences, Paris

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY